Immix Biopharma (IMMX) Stock Forecast for 2023 – 2026. Sell or Buy?
Last update: June 8, 2023 (07:07)Sector: Healthcare
The share price of Immix Biopharma, Inc. (IMMX) now
50/200 Day Moving Average: $1.98 / $1.823
This figure corresponds to the Average Price over the previous 50/200 days. For Immix Biopharma stocks, the 50-day moving average is the resistance level today.
For Immix Biopharma stocks, the 200-day moving average is the support level today.
Are you interested in Immix Biopharma, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Immix Biopharma stock price in 2023, 2024, 2025, 2026, 2027. How much will one Immix Biopharma share be worth in 2023 - 2027?
When should I take profit in Immix Biopharma stock? When should I record a loss on Immix Biopharma stock? What are analysts' forecasts for Immix Biopharma stock? What is the future of Immix Biopharma stock? We forecast Immix Biopharma stock performance using neural networks based on historical data on Immix Biopharma stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Immix Biopharma stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Immix Biopharma shares. This happens once a day.
Historical and forecast chart of Immix Biopharma stock
The chart below shows the historical price of Immix Biopharma stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Immix Biopharma stock price can be found in the table below.
Long-term forecasts by years.
Immix Biopharma daily forecast for a month
Immix Biopharma Daily Price Targets
Immix Biopharma Stock Forecast 06-10-2023.
Forecast target price for 06-10-2023: $1.97.
Negative dynamics for Immix Biopharma shares will prevail with possible volatility of 5.573%.
Pessimistic target level: 1.92
Optimistic target level: 2.03
Immix Biopharma Stock Forecast 06-11-2023.
Forecast target price for 06-11-2023: $1.95.
Negative dynamics for Immix Biopharma shares will prevail with possible volatility of 7.743%.
Pessimistic target level: 1.87
Optimistic target level: 2.03
Immix Biopharma Stock Forecast 06-12-2023.
Forecast target price for 06-12-2023: $1.89.
Negative dynamics for Immix Biopharma shares will prevail with possible volatility of 7.525%.
Pessimistic target level: 1.81
Optimistic target level: 1.96
Immix Biopharma Stock Forecast 06-13-2023.
Forecast target price for 06-13-2023: $1.84.
Negative dynamics for Immix Biopharma shares will prevail with possible volatility of 6.792%.
Pessimistic target level: 1.77
Optimistic target level: 1.90
Immix Biopharma Stock Forecast 06-14-2023.
Forecast target price for 06-14-2023: $1.81.
Negative dynamics for Immix Biopharma shares will prevail with possible volatility of 3.755%.
Pessimistic target level: 1.79
Optimistic target level: 1.86
Immix Biopharma Stock Forecast 06-15-2023.
Forecast target price for 06-15-2023: $1.79.
Negative dynamics for Immix Biopharma shares will prevail with possible volatility of 6.026%.
Pessimistic target level: 1.71
Optimistic target level: 1.82
IMMX (IMMX) Monthly Stock Prediction for 2023
Immix Biopharma forecast for this year
Immix Biopharma Stock Prediction for Jul 2023
An downtrend is forecast for this month with an optimal target price of $1.8778. Pessimistic: $1.78. Optimistic: $2.06
Immix Biopharma Stock Prediction for Aug 2023
An uptrend is forecast for this month with an optimal target price of $2.26819. Pessimistic: $1.97. Optimistic: $2.38
Immix Biopharma Stock Prediction for Sep 2023
An downtrend is forecast for this month with an optimal target price of $2.22056. Pessimistic: $2.02. Optimistic: $2.46
Immix Biopharma Stock Prediction for Oct 2023
An downtrend is forecast for this month with an optimal target price of $1.93611. Pessimistic: $1.66. Optimistic: $2.23
Immix Biopharma Stock Prediction for Nov 2023
An uptrend is forecast for this month with an optimal target price of $2.02149. Pessimistic: $1.89. Optimistic: $2.27
Immix Biopharma Stock Prediction for Dec 2023
An uptrend is forecast for this month with an optimal target price of $2.26771. Pessimistic: $1.91. Optimistic: $2.52
Immix Biopharma (IMMX) Monthly Stock Prediction for 2024
Immix Biopharma (IMMX) Monthly Stock Prediction for 2025
Immix Biopharma (IMMX) Monthly Stock Prediction for 2026
Immix Biopharma (IMMX) Monthly Stock Prediction for 2027
Immix Biopharma information and performance
Immix Biopharma is a United States-based clinical stage biopharmaceutical company with a division in Australia (Immix Biopharma Australia).
Immix Biopharma conducts research in the treatment of cancer and inflammatory diseases. The company’s key experimental line, IMX-110, is in phase 1b / 2a clinical trials and is being investigated for efficacy in the treatment of solid tumors. Tests are taking place in the United States and Australia.
11400 WEST OLYMPIC BLVD., SUITE 200, LOS ANGELES, CA, US
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.